目的 应用抑制性消减杂交技术(SSH)筛选人肾癌差异表达基因,并探讨其对肾癌生物学功能和耐药的影响.方法 从人肾透明细胞癌细胞株RLC-310和正常细胞株HK-2中提取mRNA,应用SSH技术获得肾癌细胞差异表达基因文库,筛选差异表达最明显的基因.以逆转录聚合酶链反应(RT-PCR)和Western blot法验证差异表达基因的表达.构建干扰载体沉默人肾癌RLC-310和GRC-1细胞中差异表达基因SIPL1的表达,分别采用细胞计数法、四甲基偶氮唑蓝(MTr)法和裸鼠移植瘤实验检测RLC-310和GRC-1细胞的增殖能力,流式细胞仪检测细胞周期,MTT法检测对阿霉素的耐药性.结果 构建了人肾癌细胞差异表达基因文库,筛选了12种差异表达基因,其中SIPL1基因的表达差异最为明显.RT-PCR和Western blot法验证SIPL1基因在人肾癌细胞系及肾透明细胞癌组织中高表达.SIPL1 shRNA重组质粒稳定转染至RLC-310和GRC-1细胞后,可明显下调SIPL1蛋白的表达.与转染阴性对照组细胞比较,转染SIPL1 shRNA组细胞的增殖能力均明显下降(P<0.05),肿瘤形成能力明显减弱[转染SIPL1 shRNA组和阴性对照组RLC-310细胞的裸鼠移植瘤重量分别为(0.22±0.07)g和(0.85±0.06)g,转染SIPL1 shRNA组和阴性对照组GRC-1细胞的裸鼠移植瘤重量分别为(0.32±0.07)g和(1.21±0.11)g,均P<0.05],Go/G1期细胞的比例增加[转染SIPL1shRNA组和阴性对照组RLC-310细胞中Go/G1期细胞的比例分别为(71.13±4.58)%和(53.27±3.34)%,转染SIPL1 shRNA组和阴性对照组GRC-1细胞中Go/G1期细胞的比例分别为(73.83±3.97)%和(59.33 ±3.03)%,均P<0.05],对阿霉素的敏感性提高(P<0.05).沉默SIPL1基因表达可以使AKT通路失活,同时细胞周期抑制蛋白p27Kip1和p21ap1的表达增加.结论 应用SSH技术成功筛选出肾癌差异表达基因SIPL1.SIPL1基因是一个肾癌促进基因,可能成为肾癌诊断和治疗的新靶点.
Objective To screen the differentially expressed genes in human renal clear-cell carcinoma (RCC) cells using suppression subtractive hybridization (SSH),and to explore their biological function and underlying mechanism in RCC cells.Methods Total RNAs were extracted from human renal clear-cell carcinoma cell line RLC-310 and human normal renal cell line HK-2 cells,and SSH technology was used to construct a RCC cell library of differential expression genes and to screen the most differentially expressed genes.RNA interference vector was constructed to silence the expression of the differentially expressed gene SIPL1 in human renal cell lines RLC-310 and GRC-1.Proliferation index was estimated by cell counting,MTT and tumor xenograft assay.Cell cycle analysis was performed using fluorescence activated cell sorting.Drug resistance potential to adriamycin was assessed by MTT.Results A subtractive cDNA library of highly expressed genes in the RCC cells was constructed and 12 differentially e